With an aortic root measuring 3.8 cm, should I obtain a computed tomography angiography (CTA)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 12, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

No, you do not need a CTA for a 3.8 cm aortic root

An aortic root measuring 3.8 cm is within normal limits for most adults and does not require computed tomography angiography (CTA) at this time. This measurement falls well below any threshold that would trigger intervention or necessitate advanced cross-sectional imaging.

Normal Aortic Root Dimensions

The normal adult thoracic aorta measures between 3.5 and 4.0 cm at the aortic root, with larger diameters seen particularly in older males 1. Your measurement of 3.8 cm is therefore within the expected normal range. An aneurysm is defined as dilatation ≥50% over normal diameter, or alternatively when the aortic diameter is more than two standard deviations above the mean for the patient's sex and age 1.

When CTA Would Be Indicated

CTA becomes appropriate in specific clinical scenarios:

  • Aortic diameter ≥5.5 cm - This is the primary threshold for surgical consideration in asymptomatic patients with degenerative aneurysms 2, 3
  • Rapid growth rate - ≥0.3 cm/year over 2 consecutive years, or ≥0.5 cm in 1 year 3
  • Symptomatic patients - Chest or back pain suggesting expansion 2, 3
  • Pre-intervention planning - When aneurysms reach surgical thresholds 4

For smaller aneurysms (4.0-5.5 cm), CTA may be helpful in describing aneurysm morphology, particularly for saccular aneurysms which carry increased rupture risk 4. However, at 3.8 cm, you are not in this category.

Appropriate Surveillance Strategy

For your 3.8 cm aortic root, transthoracic echocardiography (TTE) is the appropriate surveillance modality 5, 3. The 2022 ACC/AHA guidelines recommend that aortic diameters be measured at reproducible anatomic landmarks perpendicular to the axis of blood flow 3.

If you have specific risk factors (Marfan syndrome, bicuspid aortic valve, family history of aortic disease, connective tissue disorders), different thresholds apply and you should undergo baseline cross-sectional imaging with CT or MRI to confirm measurements 2, 3. In these genetic conditions, surgical intervention is considered at much smaller diameters (4.0-5.0 cm depending on the specific condition) 2.

Key Caveats

  • Measurement technique matters: TTE tends to underestimate aortic size compared to CTA, particularly for larger aneurysms 6, 7. However, at 3.8 cm, this difference is not clinically significant
  • Indexed measurements: In patients with extreme height (>1 standard deviation above or below mean), indexed parameters like aortic height index (AHI ≥3.21 cm/m) or cross-sectional area to height ratio (CSAH ≥10 cm²/m) may provide better risk stratification 3, 6
  • Radiation exposure: CTA delivers significantly higher radiation doses (approximately 11.8-fold higher) compared to non-contrast CT 8, making it inappropriate for routine surveillance of normal-sized aortas

Bottom line: Continue routine echocardiographic surveillance if clinically indicated based on your overall cardiovascular risk profile, but CTA is not warranted for a 3.8 cm aortic root in the absence of symptoms, rapid growth, or genetic risk factors.

References

Guideline

acr appropriateness criteria<sup>®</sup> suspected thoracic aortic aneurysm.

Journal of the American College of Radiology, 2018

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.